Viewpoint Capital Management’s AbbVie ABBV Stock Holding History

Viewpoint Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$542K	Sell	2,152 -870	-29%	-$187K	0.28%	58
2026 Q1	$657K	Sell	3,022 -35	-1%	-$7.76K	0.31%	60
2025 Q4	$698K	Hold	3,057	–	–	0.3%	61
2025 Q3	$708K	Hold	3,057	–	–	0.31%	60
2025 Q2	$567K	Hold	3,057	–	–	0.28%	62
2025 Q1	$641K	Hold	3,057	–	–	0.34%	57
2024 Q4	$543K	Hold	3,057	–	–	0.29%	62
2024 Q3	$595K	Hold	3,057	–	–	0.33%	56
2024 Q2	$524K	Hold	3,057	–	–	0.32%	57
2024 Q1	$557K	Sell	3,057 -100	-3%	-$17.2K	0.35%	55
2023 Q4	$489K	Hold	3,157	–	–	0.34%	58
2023 Q3	$471K	Hold	3,157	–	–	0.38%	51
2023 Q2	$425K	Buy	+3,157	New	+$463K	0.33%	59

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Viewpoint Capital Management's ABBV Position: Q2 2026 in Review

Viewpoint Capital Management reduced its AbbVie (ABBV) stake by 29% in Q2 2026, selling an estimated $187K and leaving 2,152 shares worth $542K. The position accounts for 0.28% of the portfolio, ranked #58.

Viewpoint Capital Management first reported a position in ABBV in Q2 2023 and has held it in 13 quarters since. The position peaked at $708K in Q3 2025. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Viewpoint Capital Management held 2,152 shares of AbbVie worth $542K as of Q2 2026.
Viewpoint Capital Management sold 870 AbbVie shares in Q2 2026, an estimated $187K.
AbbVie made up 0.28% of Viewpoint Capital Management's portfolio in Q2 2026, its #58 holding.
Viewpoint Capital Management first reported a position in AbbVie in Q2 2023 and has held it in 13 quarters since.
Viewpoint Capital Management's AbbVie position peaked at $708K in Q3 2025.
4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Viewpoint Capital Management's 13F filing for Q2 2026, filed 4 Aug 2026.